Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baudax Bio Inc (NQ: BXRX )

3.410 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,618
Open 3.410
Bid (Size) 3.400 (1)
Ask (Size) 3.450 (1)
Prev. Close 3.410
Today's Range 3.410 - 3.410
52wk Range 1.550 - 291.06
Shares Outstanding 20,003,745
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga

Performance

YTD
-1.45%
-1.45%
1 Month
+3.96%
+3.96%
3 Month
-51.92%
-51.92%
6 Month
-89.21%
-89.21%
1 Year
-98.75%
-98.75%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Baudax Bio Shares Trading Higher Today
Via Benzinga
Why Is Baudax Bio (BXRX) Stock Up 50% Today?
Via InvestorPlace
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Via MarketBeat
Dow Rises 80 Points; Altamira Therapeutics Shares Plunge
Via Benzinga
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks Static As Earnings Season Heats Up
Via Talk Markets
Dow Edges Higher; Crude Oil Down 1%
Via Benzinga
Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
From Baudax Bio, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030
Via FinancialNewsMedia
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket
Via Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Surges 250 Points; Jobless Claims Rise To 225,000
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
The 7 Most Sold-Off Stocks of 2022
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.